• DOI:10.1161/01.ATV.0000224325.96659.53
Corpus ID: 12778600

Less Effect of Intranasal Than Oral Hormone Therapy on Factors Associated With Venous Thrombosis Risk in Healthy Postmenopausal Women

@article{Hemelaar2006LessEO,
  title={Less Effect of Intranasal Than Oral Hormone Therapy on Factors Associated With Venous Thrombosis Risk in Healthy Postmenopausal Women},
  author={M. Hemelaar and J. Rosing and P. Kenemans and M. Thomassen and D. Braat and M. J. van der Mooren},
  journal={Arteriosclerosis, Thrombosis, and Vascular Biology},
  year={2006},
  volume={26},
  pages={1660-1666}
}

• M. Hemelaar, J. Rosing, +3 authors M. J. van der Mooren
• Published 2006
• Medicine
• Arteriosclerosis, Thrombosis, and Vascular Biology

Objective—To compare the effects of intranasal and oral administration of 17&bgr;-estradiol (E2) and norethisterone(acetate) [NET(A)] in healthy postmenopausal women on activated protein C (APC) resistance and other hemostatic parameters associated with venous thrombosis. Methods and Results—In this 2-center, randomized, double-blind, 1-year trial, 90 postmenopausal women (56.6±4.7 years of age) received daily either an intranasal spray with 175 &mgr;g/275 &mgr;g E2/NET (n=47) or 1 mg/0.5 mg… Expand